So did anyone pick up on what Nick said in his e-mail earlier?
It looks like MDIN is already in the crosshairs of a large company for an acquisition. If you think about it WHY NOT.....
MDIN's O/S is roughly 732.5mil. 450MIL of this is from patent purchase. So if you remove that amount from the O/S we are talking about "roughly" 282.5mil shares.
Looking at things like that, a "large company" could come in and offer Nick (he has super voting rights) .20 per share and still be in a great profitable position in the near future. They are spending $146.5 mil for the patent and 56.5 Mil for the company.
Sounds like a TON of money, but if you break it down a bit the number gets more and more realistic. Plus they could issue a combo of cash/shares.
According to Nick the buyback is trying to get a total of 80mil or so. So take that OUT of the total amount because the "large company" would just be paying itself unless they cancelled them, but either way it wouldn't cost the company anything.
So $56.5mil now turns into roughly $40.5mil. NOW take that number and divide it by 4. MDIN with ONLY snorenz pulled in $5.6mil in rev in 1 Q alone, now add the new (as of April) HE pet product along side it and Amazon.com's sales. To say MDIN is worth $10mil per Q is NOT a huge stretch by any means on it's own. NOW imagine a large company using it's resources with these already profitable products.
This "large company" would be buying a profitable subsidiary that could pay for itself in 2-3 years then start to bring in large profits.
What about the patent...... This company would own a patent for a cure, not to treat symptoms but CURE, an issue that affects roughly 65-75% of the population and they would own it for a VERY small price tag of UNDER $150mil. This patent could double that amount in PROFIT in less than 2 years.
SO in summation to say MDIN is a acquisition target and the premium price per share could be .20, IS very realistic.....ALL IMO OF COURSE.
